✦ LIBER ✦

PCV23 COMPARING THE EFFECTIVENESS OF ROSUVASTATIN AND ATORVASTATIN IN PREVENTING CARDIOVASCULAR OUTCOMES: ESTIMATES USING THE ARCHIMEDES MODEL

✍ Scribed by C.A. Schuetz; A. van Herick; P. Alperin; B. Peskin; J. Hsia; S.K. Gandhi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV13 Comparing the Effectiveness of Ros

✍ C.A. Schuetz; A. Van herick; P.E. Alperin; B.R. Peskin; J. Hsia; S.K. Gandhi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

PCV6 A META-ANALYSIS OF EFFICACY OF ATOR

✍ MA Villasis-Keever; ME Rendón-Masías; R Pineda-Cruz; A Escamilla-Nuñez; JF Mould 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PCV91 THE COST-EFFECTIVENESS OF ROSUVAST

✍ AG Olsson; MM Jensen; SK Gandhi; KM Fox; T Paulsson 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PCV90 THE COST-EFFECTIVENESS OF ROSUVAST

✍ AG Olsson; MM Jensen; SK Gandhi; L Smolen; T Paulsson 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Cost Effectiveness of Rosuvastatin in Tr

✍ Paul S.J. Miller; Dean G. Smith; Peter Jones 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 226 KB

PCV94 THE COST-EFFECTIVENESS OF TITRATIO

✍ D Van den Steen; C Petit; M Lamotte 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB